2026. Development and Optimization of Acyl Chitosan-based SNEDDS for enhanced Oral Bioavailability of Lipophilic Drugs. International Journal of Pharmaceutical Drug Design. 3, 1 (Jan. 2026), 22–27. DOI:https://doi.org/10.62896/.